Carbon Nanosyringe Array as a Platform for Intracellular Delivery
- 2 March 2009
- journal article
- letter
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 9 (4), 1325-1329
- https://doi.org/10.1021/nl802962t
Abstract
We report a novel platform for intracellular delivery of genetic material and nanoparticles, based on vertically aligned carbon nanosyringe arrays (CNSAs) of controllable height. Using this technology, we have shown that plasmid and quantum dots can be efficiently delivered to the cytoplasm of cancer cells and human mesenchymal stem cells. The CNSA platform holds great promise for a myriad of applications including cell-based therapy, imaging, and tracking in vivo, and in biological studies aimed at understanding cellular function.Keywords
This publication has 30 references indexed in Scilit:
- Bone marrow–derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculatureBlood, 2008
- Potential of mesenchymal stem cell therapyCurrent Opinion in Oncology, 2007
- Decreased Tumor Surveillance after Adoptive T-Cell TherapyCancer Research, 2007
- Injectable Mesenchymal Stem Cell Therapy for Large Cartilage Defects—A Porcine ModelThe International Journal of Cell Cloning, 2007
- Prospects for the use of NK cells in immunotherapy of human cancerNature Reviews Immunology, 2007
- Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell nicheNature Clinical Practice Cardiovascular Medicine, 2007
- Design and development of polymers for gene deliveryNature Reviews Drug Discovery, 2005
- Effective gene transfer to solid tumors using different nonviral gene delivery techniques: Electroporation, liposomes, and integrin-targeted vectorCancer Gene Therapy, 2002
- Stem cell therapy and gene transfer for regenerationGene Therapy, 2000
- Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancerProceedings of the National Academy of Sciences, 1997